IFN-I can promote the tumor antigen cross-presentation to naïve CD8+ T cells by stimulating DC (including CD8α+ DCs) maturation and migration to lymph nodes and thus clonal expansion and differentiation into cytotoxic effector CD8+ T cells indirectly. The gene discussed is CD8A; the disease is neoplasm.